BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.verified

BCTX

Price:

$12.24

Market Cap:

$23.15M

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Industry

Biotechnology

IPO Date

2012-03-14

Stock Exchange

NASDAQ

Ticker

BCTX

The PE Ratio as of December 2025 (TTM) for BriaCell Therapeutics Corp. (BCTX) is -0.20

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.20. This represents a change of -98.38% compared to the average of -12.33 of the last 4 quarters.

BriaCell Therapeutics Corp. (BCTX) Historical PE Ratio (quarterly & annually)

How has BCTX PE Ratio performed in the past?

The mean historical PE Ratio of BriaCell Therapeutics Corp. over the last ten years is -6912.35. The current -0.20 PE Ratio has changed -99.71% with respect to the historical average. Over the past ten years (40 quarters), BCTX's PE Ratio was at its highest in in the July 2020 quarter at 83.24. The PE Ratio was at its lowest in in the January 2021 quarter at -31847.29.

Quarterly (TTM)
Annual

Average

-6912.35

Median

-83.91

Minimum

-32009.94

Maximum

49.22

BriaCell Therapeutics Corp. (BCTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.63%

Maximum Annual PE Ratio = 49.22

Minimum Annual Increase = -263.22%

Minimum Annual PE Ratio = -32009.94

Quarterly (TTM)
Annual
YearPE RatioChange
2024-18554.5236.22%
2023-51.08-41.61%
2022-87.488.89%
2021-80.34-263.22%
202049.22-100.27%
2019-18145.16-43.31%
2018-32009.9450.63%
2017-63.10-46.25%
2016-117.3984.32%
2015-63.691.88%

BriaCell Therapeutics Corp. (BCTX) Average PE Ratio

How has BCTX PE Ratio performed in the past?

The current PE Ratio of BriaCell Therapeutics Corp. (BCTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6231.03

5-year avg

-3744.84

10-year avg

-6912.35

BriaCell Therapeutics Corp. (BCTX) PE Ratio vs. Peers

How is BCTX’s PE Ratio compared to its peers?

BriaCell Therapeutics Corp.’s PE Ratio is less than Processa Pharmaceuticals, Inc. (-0.00), greater than Curis, Inc. (-0.58), greater than Entero Therapeutics, Inc. (-0.25), greater than Leap Therapeutics, Inc. (-0.80), greater than Palisade Bio, Inc. (-1.20), greater than Hoth Therapeutics, Inc. (-1.54), greater than Allarity Therapeutics, Inc. (-1.12), greater than Moleculin Biotech, Inc. (-0.28), less than Aspire Biopharma Holdings, Inc. (-0.16), greater than Citius Pharmaceuticals, Inc. (-0.34),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is BriaCell Therapeutics Corp.'s PE Ratio?

How is the PE Ratio calculated for BriaCell Therapeutics Corp. (BCTX)?

What is the highest PE Ratio for BriaCell Therapeutics Corp. (BCTX)?

What is the 3-year average PE Ratio for BriaCell Therapeutics Corp. (BCTX)?

What is the 5-year average PE Ratio for BriaCell Therapeutics Corp. (BCTX)?

How does the current PE Ratio for BriaCell Therapeutics Corp. (BCTX) compare to its historical average?